Viridian says thyroid eye disease drug effective in reducing symptoms

Viridian Therapeutics (VRDN.O) said on Tuesday its experimental drug to treat patients with thyroid eye disease significantly reduced symptoms in a late-stage study, sending its shares up nearly 19% in premarket trading.